温度管理された医薬品容器の世界市場

温度管理された医薬品容器の世界市場は2030年までに88億米ドルに達する

2024年に49億米ドルと推定される温度管理された医薬品容器の世界市場は、2024年から2030年にかけてCAGR 10.1%で成長し、2030年には88億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである断熱シッパーは、CAGR 11.6%を記録し、分析期間終了時には52億米ドルに達すると予測されます。断熱容器セグメントの成長率は、分析期間中CAGR 8.0%と推定されます。

米国市場は13億米ドルと推定、中国はCAGR14.0％で成長予測

米国の温度管理された医薬品容器市場は2024年に13億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.1％と9.0％と予測されています。欧州では、ドイツがCAGR約8.0%で成長すると予測されています。

世界の温度管理された医薬品容器市場- 主要動向と促進要因まとめ

なぜ温度管理容器は医薬品サプライチェーンの完全性と患者の安全にとって重要なのか？

温度管理された医薬品容器は、温度変化に敏感な医薬品、生物製剤、ワクチンの保管・輸送中の安定性、有効性、安全性を維持するために不可欠です。インスリン、モノクローナル抗体、遺伝子治療薬、COVID-19ワクチンを含む多くの医薬品は、化学組成と治療価値を維持するために厳格な温度範囲（2～8℃、-20℃、-70℃など）を必要とします。有効な保管条件からの逸脱は、製品の劣化、規制への不適合、深刻な臨床的結果を招く可能性があります。

これらの容器は、有効なコールドチェーン・ソリューションを提供し、長距離輸送、国境を越えた物流、ラストワンマイル配送に関連するリスクを軽減します。断熱材、相変化材料（PCM）、真空パネル、場合によってはアクティブ冷凍ユニットと統合されたこれらの容器は、多様な気候やインフラ環境において中断のない温度制御を保証します。医薬品サプライチェーンが世界化し、規制の監視が強化される中、これらのコンテナは安全でコンプライアンスに準拠した製品流通を実現する重要な役割を担っています。

技術革新とデジタルモニタリングは、容器の効率とコンプライアンスをどのように向上させているのでしょうか？

材料と設計の技術的進歩により、温度制御コンテナの機能が拡大しています。新世代のパッシブ・コンテナは、高度な断熱材と高性能PCMを使用し、外部電力を必要とせずに長時間（多くの場合最長120時間）温度を維持します。一方、バッテリー駆動のコンプレッサーやサーモエレクトリックシステムを搭載したアクティブコンテナは、精密な温度制御と環境変動へのダイナミックな対応を可能にし、超低温チェーン要件に理想的です。

デジタル統合もまた、このカテゴリーを再構築しています。リアルタイム温度ロギング、GPS追跡、湿度モニタリング、衝撃/振動センサーがコンテナシステムに組み込まれ、エンドツーエンドの可視化と規制遵守のための文書化が可能になりました。クラウドベースのダッシュボードと自動化されたアラートにより、利害関係者は製品の状態をリモートで監視できるようになり、リスク軽減と監査への備えが強化されています。このようなスマートパッケージングシステムは、特に臨床試験ロジスティクスや特殊医薬品の流通において、高価値でリスクの高い医薬品輸送に不可欠であると見なされるようになってきています。

コンテナの採用を促進する治療セグメントとサプライチェーンシナリオは？

生物製剤、ワクチン、細胞治療や遺伝子治療などの先端療法は、温度変化に非常に敏感であるため、温度管理された医薬品容器の需要が最も高まっています。個別化医療や特殊医薬品の台頭により、製造からベッドサイドでの投与までコールドチェーンロジスティクスを必要とすることが多く、検証された温度保証された輸送の必要性が高まっています。季節性ワクチンプログラム、パンデミック対応活動、拡大する予防接種キャンペーンにより、コンテナの利用は増加の一途をたどっています。

これと並行して、臨床試験のサプライチェーン、特に分散型臨床試験や国際的な治験施設ネットワークを伴うサプライチェーンでは、サンプルや治験薬の生存性を維持するため、特殊なコールドチェーン包装への依存度が高まっています。人道援助ロジスティクス、温度変化に敏感な診断試薬、がん治療薬の流通も、急速に拡大している使用事例です。このような多様なアプリケーションは、医薬品ロジスティクスにおけるより広範な変革を反映しており、温度管理されたパッケージングは、運用上の付加価値ではなく、戦略上の必須要件となっています。

規制基準、持続可能性の目標、コスト圧力は市場力学にどのような影響を与えているか？

適正流通規範（GDP）、USP <1079>、IATA Perishable Goods Regulationsなどの国際的な規制枠組みへの準拠が、温度管理コンテナセグメント全体の製品設計と文書化基準を形成しています。製薬会社は、流通チェーン全体を通じて保管条件が一貫して維持されていることを証明する必要に迫られており、データロギング、資格証明書、ルート検証サポートを備えたコンテナへの需要が高まっています。

持続可能性とコスト効率は二重の課題として浮上しています。メーカーは、再利用可能な容器モデル、リサイクル可能な断熱材、環境への影響を低減する低炭素パッシブ冷却技術を模索しています。同時に、医薬品流通業者は、輸送コストを削減し、物流効率を向上させるために、積載重量比の最適化とコンテナ形式の標準化を模索しています。より多くの生物製剤がパイプラインに入り、サプライチェーンが世界に拡大する中、コスト抑制とコンプライアンス対応との緊張関係が、この分野における調達とイノベーション戦略を定義しています。

温度管理された医薬品容器市場の成長を促進する要因とは？

温度管理された医薬品容器市場は、医薬品サプライチェーンの複雑化、温度に敏感な生物製剤の普及、規制遵守と患者の安全性に対する世界の関心の高まりに後押しされ、急速に拡大しています。コールドチェーン・インフラがヘルスケア提供に不可欠となるにつれ、メーカー、物流プロバイダー、医療機関全体で、高度で有効な容器システムへの投資が加速しています。

今後の市場成長は、サプライヤーが精度、コスト効率、持続可能性、デジタルトレーサビリティのバランスをいかに効果的に取れるかにかかっています。温度管理された容器が、次世代治療、ますます分散化する医療モデル、世界化する流通網のニーズに対応できるように進化できるかどうかが、将来の医薬品コールドチェーンにおける戦略的役割を決定することになるでしょう。

セグメント

製品タイプ（断熱シッパー、断熱容器、その他の製品タイプ）、制御タイプ（アクティブ、パッシブ）、用途（冷凍、冷蔵、常温）、エンドユーザー（バイオ製薬会社、調査機関、その他のエンドユーザー）

調査対象企業の例（全43件）

• ACH Foam Technologies
• AmerisourceBergen Corporation
• Cold Chain Technologies
• Cryopak Industries Inc.
• CSafe Global
• DHL International GmbH
• DGP Intelsius
• Envirotainer AB
• Exeltainer SL
• FedEx Corporation
• Inmark Global Holdings LLC
• OMEGA Engineering
• Olympus Corporation
• Pelican BioThermal
• Saeplast
• Snyder Industries
• Softbox Systems
• Sofrigam SA
• Sonoco ThermoSafe
• va-Q-tec AG

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Temperature Controlled Pharmaceutical Containers Market to Reach US$8.8 Billion by 2030

The global market for Temperature Controlled Pharmaceutical Containers estimated at US$4.9 Billion in the year 2024, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Insulated Shippers, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth in the Insulated Containers segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 14.0% CAGR

The Temperature Controlled Pharmaceutical Containers market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 14.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 9.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Temperature Controlled Pharmaceutical Containers Market - Key Trends & Drivers Summarized

Why Are Temperature Controlled Containers Critical to Pharmaceutical Supply Chain Integrity and Patient Safety?

Temperature controlled pharmaceutical containers are indispensable in maintaining the stability, efficacy, and safety of temperature-sensitive drugs, biologics, and vaccines during storage and transportation. Many pharmaceutical products-including insulin, monoclonal antibodies, gene therapies, and COVID-19 vaccines-require strict temperature ranges (e.g., 2-8°C, -20°C, or -70°C) to preserve chemical composition and therapeutic value. Deviations from validated storage conditions can lead to product degradation, regulatory non-compliance, and severe clinical consequences.

These containers provide a validated cold chain solution, mitigating risks associated with long-distance shipping, cross-border logistics, and last-mile delivery. Integrated with thermal insulation, phase-change materials (PCMs), vacuum panels, and sometimes active refrigeration units, they ensure uninterrupted temperature control across diverse climatic and infrastructure environments. As pharmaceutical supply chains globalize and regulatory scrutiny intensifies, these containers serve as critical enablers of secure and compliant product distribution.

How Are Innovation and Digital Monitoring Enhancing Container Efficiency and Compliance?

Technological advancements in materials and design are expanding the capabilities of temperature controlled containers. New-generation passive containers use advanced insulation and high-performance PCMs to maintain temperature for extended durations-often up to 120 hours-without requiring external power. Meanwhile, active containers equipped with battery-powered compressors or thermoelectric systems enable precise temperature control and dynamic response to environmental fluctuations, ideal for ultra-cold chain requirements.

Digital integration is also reshaping the category. Real-time temperature logging, GPS tracking, humidity monitoring, and shock/vibration sensors are now embedded into container systems, enabling end-to-end visibility and documentation for regulatory compliance. Cloud-based dashboards and automated alerts allow stakeholders to monitor product condition remotely, enhancing risk mitigation and audit readiness. These smart packaging systems are increasingly seen as essential for high-value, high-risk pharmaceutical shipments, particularly in clinical trial logistics and specialty medicine distribution.

Which Therapeutic Segments and Supply Chain Scenarios Are Driving Container Adoption?

Biologics, vaccines, and advanced therapies such as cell and gene therapies are driving the highest demand for temperature controlled pharmaceutical containers due to their extreme sensitivity to thermal variation. The rise of personalized medicine and specialty drugs, which often require cold chain logistics from manufacturing to bedside administration, has intensified the need for validated, temperature-assured transport. Seasonal vaccine programs, pandemic response efforts, and expanded immunization campaigns continue to elevate container utilization.

In parallel, clinical trial supply chains-particularly those involving decentralized trials and international site networks-are increasingly reliant on specialized cold chain packaging to maintain sample and investigational product viability. Humanitarian aid logistics, temperature-sensitive diagnostic reagents, and oncology drug distribution also represent fast-growing use cases. These varied applications reflect a broader transformation in pharmaceutical logistics, where temperature-controlled packaging has become a strategic imperative rather than an operational add-on.

How Are Regulatory Standards, Sustainability Goals, and Cost Pressures Influencing Market Dynamics?

Compliance with international regulatory frameworks such as Good Distribution Practice (GDP), USP <1079>, and IATA Perishable Goods Regulations is shaping product design and documentation standards across the temperature controlled container segment. Pharmaceutical companies are under pressure to demonstrate that storage conditions were consistently maintained throughout the distribution chain, prompting demand for containers with data logging, qualification certificates, and route validation support.

Sustainability and cost-efficiency are emerging as dual imperatives. Manufacturers are exploring reusable container models, recyclable insulation materials, and lower-carbon passive cooling technologies to reduce environmental impact. At the same time, pharmaceutical distributors are seeking optimized payload-to-weight ratios and standardized container formats to cut freight costs and improve logistics efficiency. As more biologics enter the pipeline and supply chains stretch globally, the tension between cost containment and compliance readiness is defining procurement and innovation strategies in this space.

What Are the Factors Driving Growth in the Temperature Controlled Pharmaceutical Containers Market?

The temperature controlled pharmaceutical containers market is expanding rapidly, propelled by the growing complexity of pharmaceutical supply chains, the proliferation of temperature-sensitive biologics, and the rising global focus on regulatory compliance and patient safety. As cold chain infrastructure becomes integral to healthcare delivery, investments in advanced, validated container systems are accelerating across manufacturers, logistics providers, and healthcare institutions.

Looking ahead, market growth will hinge on how effectively suppliers can balance precision, cost-efficiency, sustainability, and digital traceability. Whether temperature controlled containers can evolve to meet the needs of next-generation therapies, increasingly decentralized care models, and globalized distribution networks will define their strategic role in the pharmaceutical cold chain of the future.

SCOPE OF STUDY:

The report analyzes the Temperature Controlled Pharmaceutical Containers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Insulated Shippers, Insulated Containers, Other Product Types); Control Type (Active, Passive); Application (Frozen, Chilled, Ambient); End-User (Biopharmaceutical Companies, Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• ACH Foam Technologies
• AmerisourceBergen Corporation
• Cold Chain Technologies
• Cryopak Industries Inc.
• CSafe Global
• DHL International GmbH
• DGP Intelsius
• Envirotainer AB
• Exeltainer SL
• FedEx Corporation
• Inmark Global Holdings LLC
• OMEGA Engineering
• Olympus Corporation
• Pelican BioThermal
• Saeplast
• Snyder Industries
• Softbox Systems
• Sofrigam SA
• Sonoco ThermoSafe
• va-Q-tec AG

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Temperature Controlled Pharmaceutical Containers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Vaccine Logistics and Biologics Supply Chains Drive High-Performance Temperature Controlled Container Demand
  • GDP Compliance and Cold Chain Integrity Requirements Reinforce Role of Passive and Active Transport Solutions
  • IoT and Data Logger Integration Supports Real-Time Temperature, Location, and Shock Monitoring
  • Reusable Container Programs Expand Among Major Distributors to Reduce Packaging Waste and Costs
  • Regional Distribution Expansion in LMICs Spurs Demand for Affordable, Portable Insulated Solutions
  • Smart RFID Tags and Blockchain-Enabled Audit Trails Improve Traceability and Compliance
  • Demand Rises for Last-Mile Controlled Containers for Home Delivery and DTP Models
  • Biologics, Gene Therapies, and Cell Therapies Push Innovation in Ultra-Cold Shipping Technologies
  • Modular Container Designs Support Multi-Route Deployment and Air, Land, Sea Compatibility
  • Emergency Response and Humanitarian Aid Programs Drive Portable Cold Chain Equipment Uptake
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Temperature Controlled Pharmaceutical Containers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Insulated Shippers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Insulated Shippers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Insulated Shippers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Insulated Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Insulated Containers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Insulated Containers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Active by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Frozen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Chilled by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Chilled by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Chilled by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Ambient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Ambient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Ambient by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• JAPAN
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• CHINA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• EUROPE
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• FRANCE
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• GERMANY
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• INDIA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030
• AFRICA
  • Temperature Controlled Pharmaceutical Containers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by Product Type - Insulated Shippers, Insulated Containers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Product Type - Percentage Breakdown of Value Sales for Insulated Shippers, Insulated Containers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by End-user - Research Institutes, Other End-Users and Biopharmaceutical Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by End-user - Percentage Breakdown of Value Sales for Research Institutes, Other End-Users and Biopharmaceutical Companies for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by Control Type - Active and Passive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Control Type - Percentage Breakdown of Value Sales for Active and Passive for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Temperature Controlled Pharmaceutical Containers by Application - Frozen, Chilled and Ambient Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Temperature Controlled Pharmaceutical Containers by Application - Percentage Breakdown of Value Sales for Frozen, Chilled and Ambient for the Years 2015, 2025 & 2030

IV. COMPETITION